- Home
- IQV vs CLS Comparison
IQV vs CLS Comparison
Compare IQV & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- CLS
- Stock Information
- Founded
- IQV 1982
- CLS 1994
- Country
- IQV United States
- CLS Canada
- Employees
- IQV N/A
- CLS N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- CLS Electrical Products
- Sector
- IQV Health Care
- CLS Technology
- Exchange
- IQV Nasdaq
- CLS Nasdaq
- Market Cap
- IQV 36.4B
- CLS 31.1B
- IPO Year
- IQV 2013
- CLS 1998
- Fundamental
- Price
- IQV $208.58
- CLS $319.17
- Analyst Decision
- IQV Buy
- CLS Buy
- Analyst Count
- IQV 18
- CLS 13
- Target Price
- IQV $237.89
- CLS $296.08
- AVG Volume (30 Days)
- IQV 1.8M
- CLS 3.2M
- Earning Date
- IQV 10-28-2025
- CLS 10-27-2025
- Dividend Yield
- IQV N/A
- CLS N/A
- EPS Growth
- IQV N/A
- CLS 103.66
- EPS
- IQV 7.30
- CLS 6.15
- Revenue
- IQV $15,904,000,000.00
- CLS $11,281,700,000.00
- Revenue This Year
- IQV $6.14
- CLS $20.66
- Revenue Next Year
- IQV $5.28
- CLS $19.38
- P/E Ratio
- IQV $28.87
- CLS $55.39
- Revenue Growth
- IQV 3.85
- CLS 22.09
- 52 Week Low
- IQV $134.65
- CLS $58.05
- 52 Week High
- IQV $225.91
- CLS $363.40
- Technical
- Relative Strength Index (RSI)
- IQV 48.29
- CLS 59.01
- Support Level
- IQV $207.01
- CLS $330.20
- Resistance Level
- IQV $212.68
- CLS $363.40
- Average True Range (ATR)
- IQV 5.80
- CLS 20.11
- MACD
- IQV -1.78
- CLS 1.26
- Stochastic Oscillator
- IQV 2.72
- CLS 60.12
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.